{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T12:28:26Z","timestamp":1730204906630,"version":"3.28.0"},"reference-count":25,"publisher":"IEEE","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1109\/cdc.2017.8264262","type":"proceedings-article","created":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T20:30:57Z","timestamp":1516739457000},"page":"4106-4111","source":"Crossref","is-referenced-by-count":0,"title":["Implications of measurement assay type in design of HIV experiments"],"prefix":"10.1109","author":[{"given":"LaMont","family":"Cannon","sequence":"first","affiliation":[]},{"given":"Aditya","family":"Jagarapu","sequence":"additional","affiliation":[]},{"given":"Cesar A.","family":"Vargas-Garcia","sequence":"additional","affiliation":[]},{"given":"Michael J.","family":"Piovoso","sequence":"additional","affiliation":[]},{"given":"Ryan","family":"Zurakowski","sequence":"additional","affiliation":[]}],"member":"263","reference":[{"key":"ref10","doi-asserted-by":"crossref","first-page":"46e","DOI":"10.1371\/journal.ppat.0030046","article-title":"ART suppresses plasma HIV-l RNA to a stable set point predicted by pretherapy viremia","volume":"3","author":"frank","year":"2007","journal-title":"PLoS Pathog"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1001\/jama.282.17.1627","article-title":"Residual HIV-l RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy","volume":"282","author":"geethanjali","year":"1999","journal-title":"JAMA"},{"key":"ref12","article-title":"Derivations for linear algebra and optimization","author":"john","year":"2007","journal-title":"U of California Berkeley"},{"key":"ref13","article-title":"Entropy-based genetic algorithm for solving TSP","volume":"2","author":"yasuhiro","year":"1998","journal-title":"Knowledge-Based Intelligent Electronic Systems 1998 Proceedings KES '98 1998 Second International Conference on"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1162\/evco.1993.1.1.1","article-title":"An overview of evolutionary algorithms for parameter optimization","volume":"1","author":"thomas","year":"1993","journal-title":"Evolutionary Computation"},{"journal-title":"Introduction to Genetic Algorithms","year":"2007","author":"sivanandam","key":"ref15"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1109\/JPROC.2003.823141"},{"key":"ref17","first-page":"79","article-title":"On information and sufficiency","author":"solomon","year":"1951","journal-title":"The Annals of Mathematical Statistics"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1128\/JCM.01254-12","article-title":"Modeling uncertainty in single-copy assays for HIV","volume":"50","author":"rutao","year":"2012","journal-title":"Journal of Clinical Microbiology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2111"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/00002030-200007070-00008","article-title":"Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression","volume":"14","author":"hiroyu","year":"2000","journal-title":"AIDS"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/infdis\/jit453","article-title":"Increase in 2long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial","volume":"208","author":"hiroyu","year":"2013","journal-title":"Journal of Infectious Diseases"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/44755","article-title":"AIDS: re-emergence of HIV after stopping therapy","volume":"401","author":"tae-wook","year":"1999","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/77481","article-title":"Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy","volume":"6","author":"tae-wook","year":"2000","journal-title":"Nature Medicine"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1126\/science.278.5341.1291"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.26.15109"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"40198e","DOI":"10.1371\/journal.pone.0040198","article-title":"HIV model parameter estimates from interruption trial data including drug efficacy and reservoir dynamics","volume":"7","author":"rutao","year":"2012","journal-title":"PLoS ONE"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1128\/JVI.78.2.968-979.2004","article-title":"Continued production of drug-sensitive human immunodeficiency virus type 1 in children on combination antiretroviral therapy who have undetectable viral loads","volume":"78","author":"deborah","year":"2004","journal-title":"Journal of Virology"},{"key":"ref1","doi-asserted-by":"crossref","first-page":"20130186","DOI":"10.1098\/rsif.2013.0186","article-title":"Modelling HIV-l 2-LTR dynamics following raltegravir intensification","volume":"10","author":"rutao","year":"2013","journal-title":"Journal of The Royal Society Interface"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055943"},{"key":"ref22","article-title":"Order preservation of expected information content using Unscented Transform approximation of multivariate prior distributions in HIV 2-LTR experiment design","author":"george","year":"2016","journal-title":"Decision and Control (CDC) 2016 IEEE 55th Conference on IEEE"},{"key":"ref21","article-title":"Prospective HIV clinical trial comparison by expected Kullback-Leibler Divergence","author":"la mont","year":"2016","journal-title":"2016 American Control Conference (ACC)"},{"key":"ref24","article-title":"University of Melbourne; The Alfred.ViiV Healthcare. Dolutegravir Impact on Residual Replication: Dolutegravir Intensification Study","author":"sharon","year":"2017","journal-title":"ClinicalTrials gov [Internet] Bethesda (MD) National Library of Medicine (US) 2000-[cited"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"12385","DOI":"10.1128\/JVI.00609-14","article-title":"Cross-clade ultrasensitive PCR-based assays to measure HIV persistence in large-cohort studies","volume":"88","author":"claire","year":"2014","journal-title":"Journal of Virology"},{"key":"ref25","first-page":"167568e","article-title":"Analysis of Practical Identifiability of a Viral Infection Model","volume":"11","author":"van kinh","year":"2016","journal-title":"PLoS ONE"}],"event":{"name":"2017 IEEE 56th Annual Conference on Decision and Control (CDC)","start":{"date-parts":[[2017,12,12]]},"location":"Melbourne, VIC","end":{"date-parts":[[2017,12,15]]}},"container-title":["2017 IEEE 56th Annual Conference on Decision and Control (CDC)"],"original-title":[],"link":[{"URL":"http:\/\/xplorestaging.ieee.org\/ielx7\/8253407\/8263624\/08264262.pdf?arnumber=8264262","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T22:20:32Z","timestamp":1605306032000},"score":1,"resource":{"primary":{"URL":"https:\/\/ieeexplore.ieee.org\/document\/8264262\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":25,"URL":"https:\/\/doi.org\/10.1109\/cdc.2017.8264262","relation":{},"subject":[],"published":{"date-parts":[[2017,12]]}}}